▶ NAD+ · SUBTOPIC · MECHANISM
NAD+ Mechanism
For Laboratory Research Use Only. The mechanistic information below is descriptive of published research. No human dose is recommended. No clinical claim is made.
MECHANISM OF ACTION
Endogenous redox coenzyme. Substrate of sirtuins, PARPs, and CD38. Drives cellular bioenergetics through glycolysis, the TCA cycle, and oxidative phosphorylation.
PHARMACOKINETIC HALF-LIFE
Reported half-life for NAD+: Short (minutes) in plasma; intracellular pools cycled continuously. Half-life determines the kinetic window across which receptor occupancy is maintained and frames the dosing rhythm used in published literature.
MECHANISM CATEGORIES
NAD+ is tagged in 3 mechanism categories on GIGARESEARCH. Each category aggregates the broader pharmacology of related compounds.
The longevity category includes compounds acting on canonical aging-biology pathways: sirtuins (NAD+-dependent deacylases), mitochondrial function and biogenesis, cellular senescence, autophagy, and the AMPK/mTOR axis. NAD+ and its precursors are the most-studied longevity compounds; MOTS-c (mitochondrial-derived peptide) is an emerging category.
Mitochondrial function encompasses oxidative phosphorylation, biogenesis (driven by PGC-1α), and quality-control processes (mitophagy). The mitochondrial-derived peptide MOTS-c regulates AMPK signaling and metabolic homeostasis. NAD+ supports the electron-transport chain and mitochondrial sirtuins (SIRT3, SIRT4, SIRT5).
Sirtuins (SIRT1–SIRT7) are NAD+-dependent class-III lysine deacylases that regulate metabolism, stress response, DNA repair, and circadian rhythm. They consume NAD+ stoichiometrically · sirtuin activity scales with cellular NAD+ availability. NAD+ precursor supplementation (NR, NMN) is the dominant translational approach for sirtuin activation.
MECHANISTIC OUTCOMES IN LITERATURE
The following outcomes are the mechanistic endpoints reported in the peer-reviewed literature, with GIGARESEARCH evidence grades. Grades reflect study quality and replication, not clinical recommendation.
Sirtuins are NAD+-dependent enzymes; sirtuin activity scales with cellular NAD+ status. Established biochemistry, decades of literature.
NR and NMN precursor trials reliably raise blood NAD+ levels. Yoshino, Imai, Baur review (PMID 29249689).
Translation of NAD+ precursor supplementation to functional endpoints (cognition, energy, metabolic markers) shows mixed results in trials. Effect sizes modest.
Direct administration of full NAD+ at the cell-membrane scale is debated; most translational interest centers on precursors that cross the plasma membrane more efficiently.
MECHANISM Q+A
▶ What's the half-life of injected NAD+?
Short · on the order of minutes in plasma. Intracellular pools are cycled continuously through the salvage pathway. Most research interest is therefore in raising intracellular NAD+ via precursors that cross the plasma membrane.
CITED LITERATURE
- Yoshino J, Baur JA, Imai S. NAD+ Intermediates: The Biology and Therapeutic Potential of NMN and NR. Cell Metab 2018. PMID 29249689. link
- Imai S, Guarente L. NAD+ and sirtuins in aging and disease. Trends Cell Biol 2014. PMID 24786309. link
- Johnson S, Imai S. NAD+ biosynthesis, aging, and disease. F1000Res 2018. PMID 29744033. link
RELATED PAGES
▶ LAST UPDATED · 2026-05-19